Conditions & Recovery · ScienceDaily Cancer · September 25, 2026

CRISPR could help doctors attack blood cancer without destroying healthy cells

Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood cancers without destroying the healthy cells patients need after a transplant. In a 30-patient trial, the edited cells successfully took hold and appeared to shield blood cells from a CD33-targeted cancer treatment.

Originally published by ScienceDaily Cancer. We curate and add context; they did the reporting.

Related learning